Nomura M, et al. - This work was planned to determine the efficacy and safety of retreatment with nivolumab in metastatic melanoma patients who previously progressed on nivolumab. Findings suggested retreatment with nivolumab as a viable option for select metastatic melanoma patients after previous nivolumab treatment.